We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Integrating Acupuncture Into the Management of Migraines

This study has been terminated.
(PI cited personal reasons)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01481103
First Posted: November 29, 2011
Last Update Posted: April 4, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National University of Health Sciences
November 22, 2011
November 29, 2011
April 4, 2013
July 2011
April 2013   (Final data collection date for primary outcome measure)
Number and intensity of migraine headaches [ Time Frame: 16 weeks ]
Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention
Same as current
Complete list of historical versions of study NCT01481103 on ClinicalTrials.gov Archive Site
Medication consumed [ Time Frame: 16 weeks ]
Participants will be asked to maintain a daily diary of headache occurrences and medication use for 4 weeks prior to intervention and 4 weeks after intervention
Same as current
Not Provided
Not Provided
 
Integrating Acupuncture Into the Management of Migraines
Integrating Acupuncture Into the Management of Migraines: A Randomized, Comparative Trial
This research is being done to study the effect of incorporating acupuncture into the management of migraines. The primary aim is to determine in a randomized, controlled study whether individuals experiencing migraines have fewer occurrences and less intense migraines when acupuncture is integrated with nonprescription pharmacological treatment. Nonprescription pharmacological treatment in this study refers to the use of the following over the counter medications: Aspirin, Ibuprofen, Naproxen, Acetaminophen (with or without caffeine). Aspirin, Ibuprofen, and Naproxen are members of a class of drugs known as non-steroidal anti-inflammatory drugs or NSAIDs.

70 men and women between the ages of 18-65 diagnosed with migraines by a medical doctor. Participants must be using only nonprescription medication to treat their head pain.

Once initial eligibility has been determined and informed consent obtained, a Traditional Chinese Medicine (TCM) differential diagnosis will be carried out to determine the underlying cause of the migraines experienced by the participant. If the migraines are due to Liver Qi stagnation with Liver Yang rising they will be eligible for participation in the study. Eligible participants will be randomly assigned to one of two groups: Group 1 will continue taking their current nonprescription migraine medication as needed and will receive acupuncture once a week for 8 weeks. Group 2 will continue with their current nonprescription migraine medication as needed but will not receive acupuncture. The same set of predetermined acupuncture points will be used at each session.

All participants will complete a daily headache and medication use diary for four weeks on two separate occasions. In addition all participants will complete the Headache Impact Test (HIT-6) survey on three separate occasions.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Migraine Headache
Procedure: Acupuncture
participants will receive 8 weekly acupuncture sessions. Acupuncture will be performed by a licensed acupuncturist. Each session will last approximately 25 minutes.
  • Active Comparator: Acupuncture group
    Participants will keep a headache diary for 4weeks and then attend eight weekly acupuncture sessions. Acupuncture will be done by a licensed acupuncturist and will last approximately 25 minutes. Following the acupuncture sessions, participants will keep a headache diary for an additional 4 weeks
    Intervention: Procedure: Acupuncture
  • No Intervention: Control group
    participants will be asked to maintain a daily diary of headache occurrences and OTC medication use for 16 weeks.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
9
April 2013
April 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Migraine with or without aura according to the International Headache Society classification and diagnosed by a Medical Doctor.
  • Subjects are required to have between 2 and 12 migraines but no more than 15 headache days (migraine or nonmigraine) per 28 days during the prospective baseline phase. A headache day is defined as a calendar day during which the patient experienced headache for at least 30 minutes.
  • Taking a nonprescription medication for the migraine pain. More specifically Aspirin, Ibuprofen, Naproxen, and/or Acetaminophen (with or without caffeine).
  • Age between 18 and 65 years.
  • A history of migraine for at least 12 months.
  • Completed at least 75% of the baseline headache diary.
  • Completion of written informed consent.

Exclusion Criteria:

  • Onset of headache disorder less than 12 months prior to age 50.
  • Pregnancy or planning to get pregnant while participating in the study.
  • Malignancy; cluster headache (IHS code 3); sinus headaches.
  • Suspicion that headache disorder has specific etiology (IHS code 5-11); cranial neuralgias (IHS code12)
  • Acupuncture treatment in the previous 12 months.
  • Taking a prescription medication for the migraine pain.
  • Subject plans to receive acupuncture for another medical condition while participating in the study.
  • Systemic disorder or illness, including serious psychiatric illness.
  • Failure to fulfill baseline information.
  • Failure to provide written informed consent.
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01481103
NUHS H1009
Yes
Not Provided
Not Provided
National University of Health Sciences
National University of Health Sciences
Not Provided
Principal Investigator: Patricia Miller, LAc, PT National University of Health Sciences
Study Director: Hui Yan Cai, LAc, PhD National University of Health Sciences
National University of Health Sciences
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP